BRIEF-Amicus Therapeutics says co on track to report top-line data from essence study during Q3
May 19, 2017 at 07:37 AM EDT
* Says Amicus is on track to report top-line data from essence study during Q3 of 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.